• OPEN AN ACCOUNT
Indian Indices
Sensex
78,079.96 113.61
( 0.15%)
Global Indices
Nasdaq
53,790.86 -21.99
(-0.04%)
Dow Jones
7,769.71 20.51
(0.26%)
Hang Seng
68,341.16 817.10
(1.21%)
Nikkei 225
10,757.72 -75.43
(-0.70%)
Forex
USD-INR
95.38 0.10
(0.10%)
EUR-INR
110.06 0.02
(0.01%)
GBP-INR
128.81 0.17
(0.13%)
JPY-INR
0.60 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Bacil Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524516
INE711D01018
17.5524281
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
13.45
20.85
EPS(TTM)
Face Value()
Div & Yield %
1.08
10
0
 

Mangalam Cement standalone net profit rises 285.75% in the March 2026 quarter
May 18,2026
Net profit of Mangalam Cement rose 285.75% to Rs 65.23 crore in the quarter ended March 2026 as against Rs 16.91 crore during the previous quarter ended March 2025. Sales declined 2.49% to Rs 490.40 crore in the quarter ended March 2026 as against Rs 502.90 crore during the previous quarter ended March 2025.

For the full year,net profit rose 186.17% to Rs 128.95 crore in the year ended March 2026 as against Rs 45.06 crore during the previous year ended March 2025. Sales rose 4.61% to Rs 1758.41 crore in the year ended March 2026 as against Rs 1680.99 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales490.40502.90 -2 1758.411680.99 5
OPM %11.0110.77 -12.339.37 -
PBDT53.8348.29 11 196.80148.62 32
PBT33.7726.97 25 115.9569.98 66
NP65.2316.91 286 128.9545.06 186